Skip to main content
. 2020 Nov 9;8:186. doi: 10.1186/s40478-020-01058-6

Fig. 3.

Fig. 3

Clinical characteristics, cancer signaling pathway alterations, and methylation profiles of 37 FGFR3-TACC3 fusion-positive glioblastomas. Note: The variants displayed are putative drivers according to OncoKB and/or the Cancer Hotspots database [14, 15]